BM

Bill Maris

North America, California, United States, San Diego

Description

Bill Maris was the Founder and CEO of GV and attended Middlebury College.

Investor Profile

Bill Maris has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bill Maris frequently co-invest with?

Green D Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 1
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 1
United Therapeutics
North America, Maryland, United States, Silver Spring
Co-Investments: 1
Human Longevity
North America, California, United States, San Diego
Co-Investments: 1
Heritage Group
North America, Tennessee, United States, Nashville
Co-Investments: 1
Section 32
North America, California, United States, San Diego
Co-Investments: 1
Sorrento Therapeutics
North America, California, United States, San Diego
Co-Investments: 1

Which angels does Bill Maris often collaborate with?

TR
North America, California, United States, San Diego
Shared Deals: 1

What are some of recent deals done by Bill Maris?

Celularity

Florham Park, New Jersey, United States

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

BiotechnologyHealth CareTherapeuticsWellness
Series UnknownFeb 15, 2018
Amount Raised: $250,000,000